Pharmaphorum - pharmaphorum.com
General Information:
Latest News:
Rare disease awareness: Alkaptonuria 7 Aug 2012 | 09:24 pm
Are enough questions being asked of patients who don’t present with typical symptoms of common diseases? Oliver Timmis of the AKU society doesn’t think so and here he explains why doing so could incre...
Pfizer, J&J to discontinue Alzheimer’s drug clinical studies 7 Aug 2012 | 06:48 pm
Pfizer and J&J discontinue all further studies for their Alzheimer’s drug, bapineuzumab, as it does not meet clinical endpoints in late Phase 3 clinical trials. Following our recent news that Pfizer ...
Novartis and Pennsylvania collaborate on cancer research 6 Aug 2012 | 11:37 pm
Novartis and the University of Pennsylvania have collaborated to research and develop CAR immunotherapies for the treatment of cancers. An exclusive global collaboration has been announced between ph...
Perspectives on CME: part 1 – what is CME? 6 Aug 2012 | 09:43 pm
In part one of this five-part interview series with Lawrence Sherman of Prova Education we discover what CME needs to deliver to be of value. How do we know if continuing medical education (CME) prog...
FDA approves Sanofi colon cancer drug, Zaltrap 6 Aug 2012 | 07:22 pm
The FDA announces it has approved Sanofi and Regeneron Pharmaceutical’s Zaltrap, in combination with FOLFIRI, to treat adult patients with metastatic colorectal cancer. The US Food and Drug Administr...
Gathering momentum to tackle antimicrobial resistance 6 Aug 2012 | 05:10 pm
We interview Dr John Rex of AstraZeneca to get an update on the NewDrugs4BadBugs programme and the challenge of antimicrobial resistance in general. Following on from our recent blog post by Dr John ...
Generic drugs saved US $1 trillion in 10 years 4 Aug 2012 | 12:10 am
A new report reveals that the use of generic prescription drugs in the US has saved consumers and the healthcare system over $1 trillion in the past ten years. In 2011, the use of generic prescriptio...
Patient perspectives: Elaine Schattner 3 Aug 2012 | 09:49 pm
We interview Elaine Schattner, breast cancer survivor, blogger and nonpracticing physician on what she thinks needs to change in order for patients’ needs to better be met. Elaine Schattner had sever...
Shire Q2 profits up 16% 3 Aug 2012 | 05:56 pm
Shire announces strong second quarter earnings, with product sales up by 16%, attributed largely by ADHD treatments, Vyvanse and Intuniv. Shire is on track to deliver double digit full year earnings ...
Rare diseases part 1: posing questions that are difficult to answer 1 Aug 2012 | 10:07 pm
Starting off our rare diseases focus month, Neil Dickinson discusses the impact of orphan drug development, looking at legislation changes and his own personal experiences. The pharmaceutical industr...
